ASPG and acute lymphoblastic leukemia: HICs are also affected, with shortages of vincristine, methotrexate and Erwinia asparaginase threatening delivery of care for children with ALL.44–46 In some cases these shortages are attributed to decrease in production because of low profits associated with the manufacturing of generic formulations.46–49